It is important to note that drug-induced lung pathology must be kept in the differential diagnosis of patients with CD taking medications such as methotrexate, sulfasalazine, anti-tumor necrosis factor (TNF)-alpha, and mesalamine, as this was shown to be responsible for 50% of interstitial lung diseases in individuals diagnosed with inflammatory bowel disease [2]. Here, TNF is linked to inflammatory bowel disease.